title: Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
authors.affiliation: Service d'Immunologie Clinique et Transplantation C.H.U., Nantes, France.
authors.forename: M
authors.initials: M
authors.lastname: Hourmant
authors.forename: J L
authors.initials: JL
authors.lastname: Taupin
authors.forename: F
authors.initials: F
authors.lastname: Leymerigie
authors.forename: D
authors.initials: D
authors.lastname: Cantarovich
authors.forename: J P
authors.initials: JP
authors.lastname: Soulillou
mesh_terms: D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D011897:Random Allocation; D014184:Transplantation, Homologous
chemical_list: D003524:Cyclosporins; D001379:Azathioprine